You are here

Duke-NUS' vaccine approved for clinical trials ahead of predicted date; first study to involve 108 volunteers

[SINGAPORE] A vaccine jointly developed by Duke-NUS Medical School and United States pharmaceutical company Arcturus Therapeutics has received approval for clinical trials.

This puts it among 24 other candidate vaccines around the world that are currently undergoing clinical evaluation....

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes